Data to be presented at SLEEP 2020 showed Eisai Inc's lemborexant (DAYVIGO) had statistically significant long-term efficacy and safety compared with placebo on sleep maintenance and onset in patients ...

The old advice to simply get eight hours misses a bigger picture, researchers say. New studies reveal that timing, ...

The Food and Drug Administration (FDA) has approved Dayvigo (lemborexant; Eisai) for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adult patients ...

NEW YORK, Dec. 20 /PRNewswire/ -- Intra-Cellular Therapies, Inc. (ITI), today announced it has initiated a sleep maintenance insomnia (SMI) Phase 2 clinical study using its drug candidate ITI-722. ITI ...

Dayvigo (lemborexant; Eisai) is now available for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adult patients. Dayvigo (lemborexant; Eisai) is ...

Looking for the best weighted blanket can feel overwhelming once you start scrolling through options that range from cooling ...

I have insomnia, but not the kind that means I struggle to fall asleep (in fact, the speed and ease with which I nod off at night put me off seeking help for years). Instead, the problem happens in ...

If you have no problem falling asleep but regularly find yourself waking up in the middle of the night without being able to go back to sleep, you might have sleep maintenance insomnia. It could ...

Adding to the growing body of evidence on sleep disturbances and cognitive impairment, new research finds significant links between three measures of sleep disturbance and the risk for developing ...